DNLI

DNLI Operating Expenses

$540.50MTTM · USD

Period ending:

DNLI FY Operating ExpensesUSD
DNLI FY Operating Expenses2015-12-31: $16.68M2016-12-31: $87.43M2017-12-31: $90.14M2018-12-31: $175.53M2019-12-31: $239.86M2020-12-31: $272.94M2021-12-31: $344.41M2022-12-31: $449.21M2023-12-31: $527.23M2024-12-31: $487.34M2025-12-31: $544.16M$544.16M$0.00
2015-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DNLI operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 11 observations from Dec 31, 2015 to Dec 31, 2025.

Denali Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
544,159,000
487,341,000
527,230,000
449,207,000
344,412,000
272,941,000
239,862,000
175,532,000
90,140,000
87,433,000
16,679,000

Compare operating expenses

All DNLI financial metrics · DNLI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.